TD Asset Management’s Cabaletta Bio CABA Stock Holding History

TD Asset Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Buy	391,472 +324,548	+485%	+$1.07M	﹤0.01%	1059
2026 Q1	$180K	Sell	66,924 -21,676	-24%	-$60.2K	﹤0.01%	1224
2025 Q4	$194K	Hold	88,600	–	–	﹤0.01%	1223
2025 Q3	$207K	Hold	88,600	–	–	﹤0.01%	1222
2025 Q2	$135K	Hold	88,600	–	–	﹤0.01%	1183
2025 Q1	$123K	Hold	88,600	–	–	﹤0.01%	1204
2024 Q4	$201K	Hold	88,600	–	–	﹤0.01%	1230
2024 Q3	$377K	Sell	88,600 -45,430	-34%	-$263K	﹤0.01%	1327
2024 Q2	$1M	Buy	134,030 +7,000	+6%	+$85.8K	﹤0.01%	1158
2024 Q1	$2.17M	Buy	127,030 +33,400	+36%	+$717K	﹤0.01%	992
2023 Q4	$2.13M	Buy	+93,630	New	+$1.57M	﹤0.01%	985

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TD Asset Management's CABA Position: Q2 2026 in Review

TD Asset Management increased its Cabaletta Bio (CABA) stake by 485% in Q2 2026, buying an estimated $1.07M and bringing the position to 391,472 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

TD Asset Management first reported a position in CABA in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.17M in Q1 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

TD Asset Management held 391,472 shares of Cabaletta Bio worth $1.22M as of Q2 2026.
TD Asset Management bought 324,548 Cabaletta Bio shares in Q2 2026, an estimated $1.07M.
Cabaletta Bio made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1059 holding.
TD Asset Management first reported a position in Cabaletta Bio in Q4 2023 and has held it in 11 quarters since.
TD Asset Management's Cabaletta Bio position peaked at $2.17M in Q1 2024.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.